Schwab Charles CORP Form 4 insider transactions

A Charles Schwab director, Arun Sarin, exercised stock options and sold shares on January 23, 2025.

Charles Schwab's General Counsel, Peter J. Morgan III, exercised stock options and sold the resulting shares on January 22, 2025.

Director Stephen A. Ellis acquired 458 restricted stock units of Charles Schwab Corp on January 2, 2025, through the Directors' Deferred Compensation Plan II.

Director Bharat Masrani acquired 407 restricted stock units of Charles Schwab Corp on January 2, 2025, through the Directors' Deferred Compensation Plan II.

Frank C. Herringer, a director at Charles Schwab, acquired restricted stock units and stock options as part of the company's deferred compensation plan.

Director Marianne Brown acquired 508 restricted stock units of Schwab (SCHW) on January 2, 2025, through the Directors' Deferred Compensation Plan II.

Charles A. Ruffel, a director of Charles Schwab Corp, acquired 1,646 nonqualified stock options on January 2, 2025, in lieu of cash compensation.

Director Carolyn Schwab-Pomerantz sold shares of Schwab (SCHW) on January 2, 2025, under a pre-arranged 10b5-1 trading plan.

Stephen A. Ellis, a director at Charles Schwab, exercised stock options and transferred the resulting shares to a revocable trust on December 18, 2024.

Carolyn Schwab-Pomerantz, a director at Charles Schwab Corp, sold a total of 9,000 shares of common stock on December 16, 2024, under a pre-arranged trading plan.

Director Carolyn Schwab-Pomerantz reported a gift of 320 shares of Charles Schwab stock and changes in indirect ownership through trusts, a spouse, and an LLC.

Jonathan Beatty, a managing director at Charles Schwab, exercised stock options and sold shares on November 25, 2024, according to a recent SEC filing.

Nigel J. Murtagh, Chief Risk Officer of Charles Schwab, sold 12,739 shares of common stock at an average price of $81.1659 on November 22, 2024.

Director Christopher Dodds of Charles Schwab exercised stock options and sold shares on November 18, 2024, according to a recent SEC filing.

Carolyn Schwab-Pomerantz, a director at Charles Schwab Corp, sold a total of 9,000 shares of common stock on November 15, 2024, under a pre-arranged trading plan.

Director Stephen A. Ellis of Charles Schwab Corp. reported the acquisition of shares through a dividend reinvestment and a transfer of shares to a trust.

Jonathan Beatty, a Managing Director at Charles Schwab, exercised stock options and sold shares, according to a recent SEC filing.

Charles Schwab director Charles A. Ruffel sold 2,998 shares of common stock at an average price of $78.6454 on November 13, 2024.

Jonathan Beatty, a Managing Director at Charles Schwab, exercised stock options and sold shares under a pre-arranged trading plan.

Paul Woolway, MD, Chief Banking Officer of Charles Schwab Corp, reports a transaction involving common stock, including a gift and holdings through a trust and ESPP.

Richard A. Wurster, a President at Charles Schwab Corp, reported the acquisition and disposal of company stock, including shares withheld for taxes upon settlement of restricted stock units.

Charles R. Schwab, Co-Chairman of Charles Schwab Corp, recently sold 17,225 shares of common stock at an average price of $70.9047.

Director Carolyn Schwab-Pomerantz sold shares of Charles Schwab Corp on October 17, 2024, according to a Form 4 filing with the SEC.

Charles Schwab, Co-Chairman of Charles Schwab Corp, exercised stock options and transferred the resulting shares to a living trust, while also selling shares on the open market.

Director Stephen A. Ellis acquired 2,145 nonqualified stock options in Charles Schwab Corp. on October 1, 2024, under the Directors' Deferred Compensation Plan II.

Charles A. Ruffel, a director of Charles Schwab Corp, acquired stock options as part of the Directors' Deferred Compensation Plan II.

Frank Herringer, a director at Schwab, acquired 2,621 nonqualified stock options on October 1, 2024, in lieu of cash compensation under the Directors' Compensation Plan II.

Director Bharat Masrani acquired 470 Restricted Stock Units (RSUs) of Schwab (SCHW) on October 1, 2024, under the Directors' Deferred Compensation Plan II.

Director Marianne Catherine Brown acquired 587 restricted stock units (RSUs) of The Charles Schwab Corporation on October 1, 2024, through the Directors' Deferred Compensation Plan II.

Carolyn Schwab-Pomerantz, a director at Charles Schwab Corp, sold shares of common stock on September 17, 2024, under a pre-arranged Rule 10b5-1 trading plan.